Damon DeSantis - 07 Aug 2024 Form 4 Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Role
Director
Signature
/s/ Damon DeSantis
Issuer symbol
INBP
Transactions as of
07 Aug 2024
Net transactions value
$0
Form type
4
Filing time
08 Aug 2024, 11:49:41 UTC
Previous filing
31 May 2024
Next filing
04 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBP Stock Option (right to buy) Award $0 +50,000 $0.000000 50,000 07 Aug 2024 Common Stock 50,000 $0.1800 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2024, December 31, 2024, March 31, 2025 and June 30, 2025.